{"id":277029,"date":"2026-09-29T11:14:55","date_gmt":"2026-09-29T05:44:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=277029"},"modified":"2026-10-07T10:25:06","modified_gmt":"2026-10-07T04:55:06","slug":"why-syncom-formulations-india-ltd-share-price-rise-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/","title":{"rendered":"Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations Share Price Rises 9.21% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-(india)-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF)<\/a> share price rose to Rs 25.38 today, up 9.21% from the previous close. Market cap was Rs 2,173.28 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Syncom Formulations Share Price is rising today after the stock moved to Rs 25.38, up 9.21%, with market capitalisation at Rs 2,173.28 crore. The latest Univest figures show a clear price rise versus the previous close, but no company-specific catalyst is established. For readers tracking Syncom Formulations Share Price Today, the main relevance is the size of the move, the intraday range and the valuation backdrop in Healthcare. According to Univest data, the stock opened at Rs 23.14, touched Rs 25.38 and traded between Rs 23.10 and Rs 25.38 as of 07 October 2026 at 10:22:41 AM IST. In this Syncom Formulations Share Price update, investors can monitor whether the move stays aligned with the company\u2019s P\/E, P\/B and return ratios while the broader healthcare pack remains part of the Market Update.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Syncom_Formulations_Share_Price_Today_Price_Action_Analysis\" title=\"Syncom Formulations Share Price Today: Price Action Analysis\">Syncom Formulations Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\" title=\"Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis\">Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Why_Investors_Are_Watching_Syncom_Formulations\" title=\"Why Investors Are Watching Syncom Formulations\">Why Investors Are Watching Syncom Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#About_Syncom_Formulations\" title=\"About Syncom Formulations\">About Syncom Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_is_Syncom_Formulations_Share_Price_today\" title=\"What is Syncom Formulations Share Price today?\">What is Syncom Formulations Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Why_is_Syncom_Formulations_Share_Price_rising_today\" title=\"Why is Syncom Formulations Share Price rising today?\">Why is Syncom Formulations Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_does_the_Syncom_Formulations_Share_Price_move_show\" title=\"What does the Syncom Formulations Share Price move show?\">What does the Syncom Formulations Share Price move show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Is_Syncom_Formulations_Share_Price_expensive_compared_with_peers\" title=\"Is Syncom Formulations Share Price expensive compared with peers?\">Is Syncom Formulations Share Price expensive compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#How_does_Syncom_Formulations_perform_on_returns\" title=\"How does Syncom Formulations perform on returns?\">How does Syncom Formulations perform on returns?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_are_the_key_valuation_numbers_for_Syncom_Formulations_Share_Price\" title=\"What are the key valuation numbers for Syncom Formulations Share Price?\">What are the key valuation numbers for Syncom Formulations Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#How_does_Syncom_Formulations_compare_with_Healthcare_peers\" title=\"How does Syncom Formulations compare with Healthcare peers?\">How does Syncom Formulations compare with Healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_sector_does_Syncom_Formulations_belong_to\" title=\"What sector does Syncom Formulations belong to?\">What sector does Syncom Formulations belong to?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Track_Syncom_Formulations_Share_Price_on_Univest\" title=\"Track Syncom Formulations Share Price on Univest\">Track Syncom Formulations Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Syncom Formulations Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23.24<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.14 (+9.21%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23.14<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,173.28 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 25.38 from the previous close of Rs 23.24, a move of Rs 2.14 or 9.21%. The stock opened at Rs 23.14, reached a high of Rs 25.38, recorded a low of Rs 23.1.<\/p>\n<p>Syncom Formulations Share Price Today shows a strong intraday rise from the previous close, with the stock trading at Rs 25.38 against Rs 23.24, a gain of Rs 2.14 or 9.21%. The share opened at Rs 23.14, moved within a band of Rs 23.10 to Rs 25.38 and last traded at the day\u2019s high. Syncom Formulations Share Price therefore reflects a sharp price action move rather than a change that can be attributed to a verified company event. According to latest Univest data, the market capitalisation stands at Rs 2,173.28 crore, which keeps the stock within the Healthcare universe while the price rise remains the core headline. For readers following Syncom Formulations Share Price Live, the immediate focus is the extent of the move versus the previous close and whether the stock can sustain this level. That takes the discussion naturally to Syncom Formulations Share Price and fundamental context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\"><\/span><strong>Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,173.28 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.91<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.43%<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P\/E 25.54x, P\/B 4.97x, ROE 20.19%, ROCE 26.8%. Read together, these ratios describe the company&#8217;s position rather than a recommendation.<\/p>\n<p>Syncom Formulations (India) Ltd. has a market capitalisation of Rs 2,173.28 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 25.54x, P\/B at 4.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.43%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 32.15x, median ROE of 11.73%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.15x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.58x to 695.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.73%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,173.28 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 816.35 crore<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 25.54x, which is below the benchmark median of 32.15x, a difference of -20.56%. The P\/E comparison frames valuation; it is not a signal to buy or sell.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.73%, a difference of +72.12%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.63%, a difference of +96.63%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,27,561.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">35.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,44,572.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,80,870.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,13,565.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,07,769.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 25.54x compared with the displayed peer median of 35.73x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 2,173.28 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Syncom_Formulations\"><\/span><strong>Why Investors Are Watching Syncom Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Syncom Formulations Share Price is up 9.21%, making it one of the clearer Stocks Rising Today in the Healthcare pack.<\/li>\n<li>Syncom Formulations Share Price is trading at Rs 25.38 versus a previous close of Rs 23.24, so the price action is easy to follow on the chart and in Syncom Formulations Stock News.<\/li>\n<li>Syncom Formulations Share Price is supported by ROE of 20.19% and ROCE of 26.80%, both above the same-industry benchmark.<\/li>\n<li>Syncom Formulations Share Price has a P\/E of 25.54, which is below the sector median and average for Pharmaceuticals &amp; Drugs.<\/li>\n<li>Syncom Formulations Share Price is being tracked alongside Healthcare sector performance and peer valuation in the Indian Stock Market.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Syncom_Formulations\"><\/span><strong>About Syncom Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Syncom Formulations (India) Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. Syncom Formulations Share Price therefore belongs to a business that is evaluated through pricing power, capital efficiency and product economics rather than broad market themes alone. The company description available in the latest Univest figures identifies it by sector and industry, which places Syncom Formulations Share Price within a regulated and competitive pharmaceutical environment. For readers following Syncom Formulations Company News, the important point is that the stock\u2019s daily move should be read alongside return ratios, valuation multiples and the industry benchmark. Syncom Formulations Share Price also matters because the company\u2019s current market capitalisation positions it well above the median company size in its same-industry benchmark. That gives Syncom Formulations Share Price a clearer comparison base against listed healthcare peers when reviewing Syncom Formulations Earnings, market cap and relative valuation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Syncom_Formulations_Share_Price_today\"><\/span><strong>What is Syncom Formulations Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price is Rs 25.38, up 9.21% from the previous close of Rs 23.24. The stock also traded between Rs 23.10 and Rs 25.38 during the reported period, with market capitalisation at Rs 2,173.28 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Syncom_Formulations_Share_Price_rising_today\"><\/span><strong>Why is Syncom Formulations Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Univest data confirms the move itself, though no company-specific trigger has been identified. Syncom Formulations Share Price is higher by Rs 2.14, and the move is visible in the day\u2019s open, high, low and last traded price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_Syncom_Formulations_Share_Price_move_show\"><\/span><strong>What does the Syncom Formulations Share Price move show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price shows a clear intraday gain from Rs 23.24 to Rs 25.38. The stock opened at Rs 23.14 and reached the day\u2019s high, which makes the price action important for short-term tracking.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Syncom_Formulations_Share_Price_expensive_compared_with_peers\"><\/span><strong>Is Syncom Formulations Share Price expensive compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price has a P\/E of 25.54 and a P\/B of 4.97. That P\/E is below the sector median of 32.15 and average of 48.45, while the P\/B is above the sector median of 2.96.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Syncom_Formulations_perform_on_returns\"><\/span><strong>How does Syncom Formulations perform on returns?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price is backed by ROE of 20.19% and ROCE of 26.80%. Both figures stand above the same-industry benchmark medians, which gives the stock a stronger return profile than many peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_valuation_numbers_for_Syncom_Formulations_Share_Price\"><\/span><strong>What are the key valuation numbers for Syncom Formulations Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price is linked to EPS of Rs 0.91, book value of Rs 4.68 and dividend yield of 0.43%. These figures help explain the stock\u2019s valuation alongside its P\/E and P\/B ratios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Syncom_Formulations_compare_with_Healthcare_peers\"><\/span><strong>How does Syncom Formulations compare with Healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price is much smaller in market-cap terms than Sun Pharma, Divi&#39;s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, but its P\/E is close to Zydus Lifesciences and below several other peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Syncom_Formulations_belong_to\"><\/span><strong>What sector does Syncom Formulations belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. That sector context matters because the stock is being compared with 199 companies in the same industry benchmark.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is Syncom Formulations Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price is Rs 25.38, up 9.21% from the previous close of Rs 23.24. The stock also traded between Rs 23.10 and Rs 25.38 during the reported period, with market capitalisation at Rs 2,173.28 crore.\"}},{\"@type\":\"Question\",\"name\":\"Why is Syncom Formulations Share Price rising today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Univest data confirms the move itself, though no company-specific trigger has been identified. Syncom Formulations Share Price is higher by Rs 2.14, and the move is visible in the day\u2019s open, high, low and last traded price.\"}},{\"@type\":\"Question\",\"name\":\"What does the Syncom Formulations Share Price move show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price shows a clear intraday gain from Rs 23.24 to Rs 25.38. The stock opened at Rs 23.14 and reached the day\u2019s high, which makes the price action important for short-term tracking.\"}},{\"@type\":\"Question\",\"name\":\"Is Syncom Formulations Share Price expensive compared with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price has a P\/E of 25.54 and a P\/B of 4.97. That P\/E is below the sector median of 32.15 and average of 48.45, while the P\/B is above the sector median of 2.96.\"}},{\"@type\":\"Question\",\"name\":\"How does Syncom Formulations perform on returns?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price is backed by ROE of 20.19% and ROCE of 26.80%. Both figures stand above the same-industry benchmark medians, which gives the stock a stronger return profile than many peers.\"}},{\"@type\":\"Question\",\"name\":\"What are the key valuation numbers for Syncom Formulations Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price is linked to EPS of Rs 0.91, book value of Rs 4.68 and dividend yield of 0.43%. These figures help explain the stock\u2019s valuation alongside its P\/E and P\/B ratios.\"}},{\"@type\":\"Question\",\"name\":\"How does Syncom Formulations compare with Healthcare peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price is much smaller in market-cap terms than Sun Pharma, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, but its P\/E is close to Zydus Lifesciences and below several other peers.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Syncom Formulations belong to?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector context matters because the stock is being compared with 199 companies in the same industry benchmark.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Syncom_Formulations_Share_Price_on_Univest\"><\/span><strong>Track Syncom Formulations Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-(india)-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Track Syncom Formulations Share Price on Univest to follow live price movement, market capitalisation, P\/E, P\/B, ROE, ROCE, EPS, book value and dividend yield in one place. Syncom Formulations Share Price Today can also be reviewed with 52-week levels and broader market insights when needed. For readers comparing Syncom Formulations Share Price with Healthcare peers, Univest keeps the company\u2019s valuation and stock performance in a single view. The platform also helps readers revisit Syncom Formulations Stock News, Syncom Formulations Latest News and Syncom Formulations Share Price Update without losing the valuation context that matters most in fundamental analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Syncom Formulations (India) Ltd. Share Price rises to Rs 25.38, marking a 9.21% rise today. Market cap stands at Rs 2,173.28 crore.<\/p>\n","protected":false},"author":35,"featured_media":291603,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-277029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["291603"],"rank_math_title":["Syncom Formulations Share Price Rises 9.21% Today"],"rank_math_description":["Syncom Formulations Share Price rose 9.21% to Rs 25.38. Read the price action, fundamentals, sector benchmark and peer comparison."],"rank_math_focus_keyword":["Syncom Formulations Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Syncom_Formulations_India_Ltd_SYNCOMF_Syncom_Formulations_Share_Price_Rises_921_Today_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/277029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=277029"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/277029\/revisions"}],"predecessor-version":[{"id":291605,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/277029\/revisions\/291605"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/291603"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=277029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=277029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=277029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}